Literature DB >> 1854976

Cell kinetics and hormonal features in relation to pathological stage in breast cancer.

D Amadori1, C Bonaguri, O Nanni, P Gentilini, N Lundi, W Zoli, A Riccobon, A Vio, E Magni, A Saragoni.   

Abstract

Proliferative activity (expressed as 3H-thymidine labeling index, 3H-TdR LI) was evaluated on a series of 281 primary tumors recruited in two years in 6 different institutions from central Italy. 3H-TdR LI proved to be low in intraductal, or well and moderately differentiated, or hormone receptor positive tumors. Conversely, no relation was observed between 3H-TdR LI and menopause, tumor size, or lymph node involvement. An inverse relation was observed between 3H-TdR LI and hormone receptor content. Specific patterns of 3H-TdR LI value and ER content association were observed as a function of menopause, lymph nodal status, and degree of lymph nodal involvement.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1854976     DOI: 10.1007/bf01975439

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  17 in total

1.  Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E.O.R.T.C. Workshop, held on 16-17 March, 1979, in the Netherlands Cancer Institute.

Authors: 
Journal:  Eur J Cancer       Date:  1980-11       Impact factor: 9.162

2.  Disease-free interval and estrogen receptor activity in tumor tissue of patients with primary breast cancer: analysis after long-term follow-up.

Authors:  J M Raemaekers; L V Beex; A J Koenders; G F Pieters; A G Smals; T J Benraad; P W Kloppenborg
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

3.  Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer.

Authors:  D W Hedley; C A Rugg; R D Gelber
Journal:  Cancer Res       Date:  1987-09-01       Impact factor: 12.701

4.  Prognostic factors for recurrence and survival in human breast cancer.

Authors:  W L McGuire
Journal:  Breast Cancer Res Treat       Date:  1987-10       Impact factor: 4.872

5.  Aneuploid DNA content and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer.

Authors:  O P Kallioniemi; T Hietanen; J Mattila; M Lehtinen; K Lauslahti; T Koivula
Journal:  Eur J Cancer Clin Oncol       Date:  1987-03

6.  Cell proliferation and its relationship to clinical features and relapse in breast cancers.

Authors:  C Gentili; O Sanfilippo; R Silvestrini
Journal:  Cancer       Date:  1981-08-15       Impact factor: 6.860

7.  The predictive value of estrogen and progesterone receptors' concentrations on the clinical behavior of breast cancer in women. Clinical correlation on 547 patients.

Authors:  L Vollenweider-Zerargui; L Barrelet; Y Wong; T Lemarchand-Béraud; F Gómez
Journal:  Cancer       Date:  1986-03-15       Impact factor: 6.860

8.  The DNA labelling index: a prognostic factor in node-negative breast cancer.

Authors:  M Héry; J Gioanni; C M Lalanne; M Namer; A Courdi
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

9.  Cell kinetics as a prognostic indicator in node-negative breast cancer.

Authors:  R Silvestrini; M G Daidone; P Valagussa; G Di Fronzo; G Mezzanotte; G Bonadonna
Journal:  Eur J Cancer Clin Oncol       Date:  1989-08

10.  Cell kinetics of solid tumors with time and its clinical implication.

Authors:  R Silvestrini; M G Daidone; A Costa
Journal:  Tumori       Date:  1989-08-31
View more
  2 in total

1.  Establishment and characterization of a new cell line from primary human breast carcinoma.

Authors:  D Amadori; L Bertoni; A Flamigni; S Savini; C De Giovanni; S Casanova; F De Paola; A Amadori; E Giulotto; W Zoli
Journal:  Breast Cancer Res Treat       Date:  1993-12       Impact factor: 4.872

2.  In vitro activity of taxol and taxotere in comparison with doxorubicin and cisplatin on primary cell cultures of human breast cancers.

Authors:  W Zoli; A Flamigni; G L Frassineti; P Bajorko; F De Paola; C Milandri; D Amadori; A Gasperi-Campani
Journal:  Breast Cancer Res Treat       Date:  1995-04       Impact factor: 4.872

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.